4//SEC Filing
Venrock Healthcare Capital Partners III, L.P. 4
Accession 0001415889-24-004790
CIK 0001348911other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:15 PM ET
Size
17.6 KB
Accession
0001415889-24-004790
Insider Transaction Report
Form 4
VHCP Co-Investment Holdings III, LLC
10% Owner
Transactions
- Purchase
Pre-Funded Warrants (Right to Buy)
2024-02-20$15.25/sh+655,738$9,999,349→ 655,738 total(indirect: By Funds)Exercise: $0.00→ Common Stock (655,738 underlying)
VHCP Management III, LLC
10% Owner
Transactions
- Purchase
Pre-Funded Warrants (Right to Buy)
2024-02-20$15.25/sh+655,738$9,999,349→ 655,738 total(indirect: By Funds)Exercise: $0.00→ Common Stock (655,738 underlying)
VHCP Management EG, LLC
10% Owner
Transactions
- Purchase
Pre-Funded Warrants (Right to Buy)
2024-02-20$15.25/sh+655,738$9,999,349→ 655,738 total(indirect: By Funds)Exercise: $0.00→ Common Stock (655,738 underlying)
Koh Bong Y
10% Owner
Transactions
- Purchase
Pre-Funded Warrants (Right to Buy)
2024-02-20$15.25/sh+655,738$9,999,349→ 655,738 total(indirect: By Funds)Exercise: $0.00→ Common Stock (655,738 underlying)
Shah Nimish P
10% Owner
Transactions
- Purchase
Pre-Funded Warrants (Right to Buy)
2024-02-20$15.25/sh+655,738$9,999,349→ 655,738 total(indirect: By Funds)Exercise: $0.00→ Common Stock (655,738 underlying)
Transactions
- Purchase
Pre-Funded Warrants (Right to Buy)
2024-02-20$15.25/sh+655,738$9,999,349→ 655,738 total(indirect: By Funds)Exercise: $0.00→ Common Stock (655,738 underlying)
Transactions
- Purchase
Pre-Funded Warrants (Right to Buy)
2024-02-20$15.25/sh+655,738$9,999,349→ 655,738 total(indirect: By Funds)Exercise: $0.00→ Common Stock (655,738 underlying)
Footnotes (3)
- [F1]Consists of (i) 172,394 securities held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 17,246 securities held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 466,098 securities held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
- [F2]The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
- [F3]VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001738048
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:15 PM ET
- Size
- 17.6 KB